JIT: Ebola Weekly Update 21 January, 2015 Lets Beat Ebola in 2015

Slides:



Advertisements
Similar presentations
EVD is a preventable but often fatal viral infection An EVD outbreak is affecting countries in West Africa where disease control resources are very limited.
Advertisements

Transmission The virus is transmitted to people from wild animals and spreads in the human population through human-to-human transmission. Human-to-human.
How can Modeling Help in Emerging Epidemics? John Grefenstette, PhD Public Health Dynamics Lab Health Policy & Management Pitt Public Health Dec 5, 2014.
EBOLA OUTBREAK 2014 There has never been an outbreak this size and severity.
Ebola: Getting the Facts. What do you know about Ebola?
Ebola Virus Disease (EVD) Updated 11:30 a.m
Ebola Virus Disease, West Africa outbreak 2014 An update on cases 21/04/2015 To update slides with most recent figures, please follow links and instructions.
Rashid A. Chotani, MD, MPH Adjunct Professor, GWU
Rashid A. Chotani, MD, MPH Adjunct Professor, GWU
Network modeling of the Ebola Outbreak Ahmet Aksoy.
Rashid A. Chotani, MD, MPH Adjunct Professor, GWU
EBOLA Kyle Draves. Pathogen Zaire Ebola Virus  Also known as EBOV  One of five viruses of the genus Ebolavirus  EBOV is most virulent of the five;
Learning from the 2009 H1N1 Pandemic Response 1 Daniel S. Miller MD, MPH Director, International Influenza Unit Office of the Secretary Office of Global.
Emerging Infections of Concern Health and Human Resources Subpanel Governor’s Secure Commonwealth Initiative March 2015.
Ebola Epidemic in Coastal West Africa – Overall Situation Report given at Caritas Internationalis Briefing Meeting 05 November 2014 Dr and Deacon Timothy.
Health Security and Emergencies Ebola Response 13 October 2014.
 An acute, severe viral infection  First appeared in 1976 in two simultaneous outbreaks  in a village near the Ebola River in the Democratic Republic.
As per CDC and WHO, Recent outbreak of Ebola Virus Disease(EVD), New cases and deaths attributable to EVD continue to be reported by the Ministries of.
Rashid A. Chotani, MD, MPH Adjunct Professor, GWU
Overview of Current Ebola Outbreak and Preparedness in Kenya Dr Ian Njeru Head, Division of Disease Surveillance and Epidemic Response 43 rd KMA Annual.
Emerging Diseases Lecture 9: Filoviruses 9.1 Overview 9.2: Outbreaks: Marburg, N’zara, Yambuku, Reston, Kikwit, West Africa 9.3 Summary.
The indirect effects of Ebola to the health system in Sierra Leone A.J. van Duinen 1,2, A. Erikson 3,4, A.M. Ekström 3, K. Brolin 3,4, H.A. Bolkan 1,2,5.
Take The Quiz. -Ebola is a severe, often fatal illness in humans -The virus was transmitted to people from wild animals and spreads in the human population.
Ebola virus disease (EVD), formerly known as Ebola haemorrhagic fever, is a severe, often fatal illness in humans. The virus is transmitted to people.
Presentation On Projects 1 & 2 Basic FETP, Liberia PREPARED BY ISAAC B. COLE COHORT I TRAINEE COUNTY SURVEILLANCE OFFICER NIMBA COUNTY.
Ebola Virus BY: HEATHER BRANDSTETTER SAMANTHA LACLAIR JENNA HENSEL DANIELLE GILFUS.
2014 Ebola outbreak in West Africa 2014 Ebola Virus Disease (EVD) Outbreak in West Africa: Status report Sarah L Barber Representative World Health Organization,
Liberia Field Epidemiology Training Programme (LFETP)Liberia Field Epidemiology Training Programme LFETP) FIELD WORK 2 -Expanded Surveillance Report- -Measles.
Using Surveillance Indicators for Vaccine-Preventable Diseases: National Notifiable Diseases Surveillance System Sandra W. Roush, MT, MPH National.
Characterization of a Large Mumps Outbreak Among Adolescents in Jerusalem, Israel in Communities Associated with Jewish Communities in New York.
Mumps Resurgence at a Large University Campus Town Awais Vaid, MBBS, MPH Epidemiologist and Director of Planning Champaign-Urbana Public Health District.
Content Public Health Emergencies
Copyright © 2017 American Academy of Pediatrics.
Ebola Virus and development
Francesco Grandesso, MSF
Ebola Virus Table Top Exercise
Health Care Worker preparedness for Ebola Virus Disease
Content Public Health Emergencies Monkey pox: Nigeria
Content Public Health Emergencies Dengue Fever: Senegal
Latest update to the National Outbreak Response group on recent trends in HIV, STIs and Hepatitis among men who have sex with men (MSM) in Ireland June.
Content Public Health Emergencies Ebola Virus Disease: DRC
Ebola Virus Disease (EVD) WHAT IS IT?
Epidemiological Update on Public Health Emergencies
Content Public Health Emergencies Lassa Fever: Nigeria
Content Public Health Emergencies Ebola Virus Disease: DRC
Content Public Health Emergencies 1 Cholera : Angola 2
Epidemiological Update on Public Health Emergencies
23 November, 2018 Update on measles & rubella surveillance in the WHO African Region – progress and challenges Dr Richard Luce WHO/IST-Central 5th African.
Content Public Health Emergencies Ebola Virus Disease: DRC
EBOLA VIRUSES (SYMPTOMS, TREATMENT AND CAUSES) Nama : Siti Sofea Annisa Binti Sheikh Mohamad No. Matric : Lecturer : Madam Siti Wahida Binti.
Epidemiological Update on Public Health Emergencies
Controlling Ebola: key role of Ebola treatment centres
Update on EVD Epidemiological Situation in Sierra Leone And Guinea WHO Country Office Liberia 20 February 2015.
Content Public Health Emergencies Ebola Virus Disease: DRC
Epidemiological Update on Public Health Emergencies
EDO UNIVERSITY IYAMHO FACULTY OF SCIENCE SEMINAR SERIES
Content Public Health Emergencies Ebola Virus Disease: DRC
West Africa Traveler Monitoring Summary
JIT: Ebola Weekly Update 04 December, 2014
Content Public Health Emergencies Lassa Fever: Nigeria
Ebola: worldwide dissemination risk and response priorities
JIT: Ebola Weekly Update 11 December, 2014
Health Protection Surveillance Centre
Stephane Helleringer, Andrew Noymer  The Lancet Global Health 
Malaria morbidity and mortality in Ebola-affected countries caused by decreased health- care capacity, and the potential effect of mitigation strategies:
Craig Conlon MD, PhD, Employee Health Services Northern California
Sexually Transmitted Infections (STIs) in Ireland, 2016
Reusable maps and graphs from ECDC Communicable Disease Threats Report Week 10, 2019 You are encouraged to reuse our maps and graphs for your own purposes.
Reusable maps and graphs from ECDC Communicable Disease Threats Report Week 36, 2019 You are encouraged to reuse our maps and graphs for your own purposes.
Presentation transcript:

JIT: Ebola Weekly Update 21 January, 2015 Lets Beat Ebola in 2015 Rashid A. Chotani, MD, MPH Adjunct Professor, GWU Chotani@gwu.edu lecture by Rashid A. Chotani Uploading date: January 27, 2015  Original file - http://www.pitt.edu/~super7/52011-53001/52971.ppt   Bibliotheca Alexandrina(BA) Just in Time (JIT) Ebola Virus Disease Supercourse http://www.pitt.edu/~super1/ResearchMethods/Ebola.htm

Highlights as of 21 January, 2014 Total Reported Cases = 21,724 [HCW: 828] Total Reported Deaths = 8,641 [HCW: 499] Overall CFR = ~40% [~60%] Case incidence Case incidence continues to fall in Guinea, Liberia, and Sierra Leone, with a halving time of 1.4 weeks in Guinea, 2.0 weeks Liberia, and 2.7 weeks in Sierra Leone A combined total of 145 confirmed cases were reported from the 3 countries in the week to 18 January: 20 in Guinea, 8 in Liberia, and 117 in Sierra Leone Mali has been declared free of EVD after completing 42 days since the last case tested negative Surveillance and information sharing will be increased in the border districts of Guinea-Bissau, Côte d’Ivoire, Mali and Senegal adjacent to the 3 intense-transmission countries Each of the intense-transmission countries has sufficient capacity to isolate and treat patients, with more than 2 treatment beds per reported confirmed, probable and suspected case The planned numbers of beds in each country has now been reduced in accordance with falling case incidence Each country has sufficient capacity to bury all people known to have died from EVD People aged 45 and over are almost 4 times more likely to be affected than are children Phase-3 trials of two candidate Ebola vaccines are set to begin at the end of January and early February in Liberia, Sierra Leone and Guinea It will take about six months for results from the phase-3 trials to be known The production of vaccines will go on while the trials are underway Huge stock of millions of doses of vaccine available by mid-year Source: WHO/CDC/SOS International/ProMed Source: WHO/CDC/SOS International/ProMed

Weekly Cases as of 21 January, 2015 These numbers are subject to change due to ongoing reclassification, retrospective investigation and availability of laboratory results. Source: WHO/CDC/SOS International Senegal declared outbreak free: 17 October Nigeria declared outbreak free: 19 October Spain declared outbreak free: 02 December Mali declared outbreak free: 21 January Mali 8 Cases & 6 Deaths Nigeria 20 Cases & 8 Deaths USA 4 Cases & 1 Death Senegal 1 Case 0 Death Spain 1 Case 0 Death UK/Scotland 1 Case 0 Death These numbers are subject to change due to ongoing reclassification, retrospective investigation and availability of laboratory results. Source: WHO/CDC/SOS International

Weekly HCW Status as of 21 January 2015 For each country the first three bars represent cases & the subsequent three bars represent deaths NOT New Cases* *The marked increase from the total of HCW infections reported last week is due to additional cases reported from Sierra Leone that have occurred since the onset of the epidemic. These are not infections that have occurred between the two most recent reporting periods. These numbers are subject to change due to ongoing reclassification, retrospective investigation and availability of laboratory results. Source: WHO/CDC/SOS International Total Cases 828 Total Deaths 499 Case-Fatality Rate ~ 60% One death in USA was a HCW infected in Guinea Mali 2 Cases & 1 Deaths Nigeria 11 Cases & 5 Deaths USA 3 Cases & 1 Death Spain 1 Case 0 Death UK 1 Case 0 Death *The marked increase from the total of HCW infections reported last week is due to additional cases reported from Sierra Leone that have occurred since the onset of the epidemic. These are not infections that have occurred between the two most recent reporting periods. These numbers are subject to change due to ongoing reclassification, retrospective investigation and availability of laboratory results. Source: WHO/CDC/SOS International

Overall Status as of 21 January, 2015 Guinea reported its lowest weekly total of new confirmed EVD cases since the week ending 17 August 2014. Case numbers remain low in Liberia, with no confirmed cases nationally for the final 2 days of the week ending 11 January, and the lowest weekly total of confirmed cases since the first week of June 2014. Sierra Leone has now reported a decline in case incidence for the second week running, and recorded its lowest weekly total of new confirmed cases since the week ending 31 August 2014. These numbers are subject to change due to ongoing reclassification, retrospective investigation and availability of laboratory results. Source: WHO These numbers are subject to change due to ongoing reclassification, retrospective investigation and availability of laboratory results. Source: WHO

Cumulative number of confirmed and probable cases by Gender and Age Strata in Guinea, Liberia, and Sierra Leone Country Cumulative Cases By Gender* (per 100,000 population) By Age Strata# Male Female 0-14 years 15-44 years 45+ years Guinea 1341 (25) 1438 (26) 443 (10) 1572 (34) 742 (47) Liberia 2538 (128) 2444 (124) 831 (48) 2653 (155) 1015 (190) Sierra Leone 4879 (171) 5150 (178) 2243 (93) 5634 (218) 2331 (315) Total 8758 9032 3517 9859 4088 These numbers are subject to change due to ongoing reclassification, retrospective investigation and availability of laboratory results. Source: UNDESA/WHO NOTE: Total for Liberia, Sierra Leone, and Guinea where sex is known but age may not be known. Cases per capita are available in the WHO external situation report. Population figures are based on estimates from the United Nations Department of Economic and Social Affairs. *Excludes cases for which data is not available on gender. #Excludes cases for which data on age are not available. These numbers are subject to change due to ongoing reclassification, retrospective investigation and availability of laboratory results. Source: UNDESA/WHO

http://www.pitt.edu/~super1/ResearchMethods/Ebola.htm